| CTRI Number |
CTRI/2021/11/038339 [Registered on: 30/11/2021] Trial Registered Prospectively |
| Last Modified On: |
18/06/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Physiotherapy (Not Including YOGA) |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Treatment of the weakness of Upper Extremity due to Stroke by virtual gaming |
|
Scientific Title of Study
|
A Comprehensive Framework for Treatment of Impairment of Upper Extremity due to Stroke by Combining Computational Modeling and Virtual Reality |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr P N Sylaja |
| Designation |
Professor of Neurology |
| Affiliation |
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram |
| Address |
Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology,
Medical College Campus, Thiruvananthapuram
Thiruvananthapuram KERALA 695011 India |
| Phone |
04712524482 |
| Fax |
|
| Email |
sylajapn@hotmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr P N Sylaja |
| Designation |
Professor of Neurology |
| Affiliation |
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram |
| Address |
Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology,
Medical College Campus, Thiruvananthapuram
Thiruvananthapuram KERALA 695011 India |
| Phone |
04712524482 |
| Fax |
|
| Email |
sylajapn@hotmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr P N Sylaja |
| Designation |
Professor of Neurology |
| Affiliation |
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram |
| Address |
Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology,
Medical College Campus, Thiruvananthapuram
Thiruvananthapuram KERALA 695011 India |
| Phone |
04712524482 |
| Fax |
|
| Email |
sylajapn@hotmail.com |
|
|
Source of Monetary or Material Support
|
| Indian Council of Medical Research |
| Ministry of Human Resource Development |
| Tata Consultancy Services |
|
|
Primary Sponsor
|
| Name |
Indian Council of Medical Research |
| Address |
V. Ramalingaswami Bhawan, P.O. Box No. 4911
Ansari Nagar, New Delhi - 110029, India |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Ministry of Human Resource Development |
122-C, Shastri Bhawan
New Delhi - 110001 |
| Tata Consultancy Services |
TCS House, Raveline Street, Fort
Mumbai 400 001, India |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Srijithesh PR |
National Institute of Mental Health and Neurosciences |
Department of Neurology,
Hosur Road, Hombegowda Nagar,
Bengaluru, Karnataka 5600029 Bangalore KARNATAKA |
08026995905
srijitheshpr@gmail.com |
| Dr P N Sylaja |
Sree Chitra Tirunal Institute for Medical Sciences and Technology |
Room No. 3109, Comprehensive Stroke Care Program, Department of Neurology, Medical College Campus, Thiruvananthapuram - 695 011, Kerala, India. Thiruvananthapuram KERALA |
04712524482
sylajapn@hotmail.com |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Sree Chitra Tirunal Institute for Medical Sciences and Technology |
Approved |
| Institutional Ethics Committee,National Institute of Mental Health and Neurosciences |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: I63||Cerebral infarction, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Physiotherapy |
Routine Physiotherapy for 3 months (Standard of care) |
| Intervention |
Virtual Gaming |
Virtual gaming will be given minimum of 3 sessions/week for 3 months |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
(a) Age between 18-70 years of age
(b) Patients with first-ever stroke with impairment of upper limb extremity function
(c) Time of stroke onset between 1-6 months
(d) Level of spasticity in upper extremity between grades 1 and 1+ based on Modified Ashworth scale
(e) Brunnstrom hand recovery stages of 4,5,6, shoulder and elbow recovery stages of 3,4,5 |
|
| ExclusionCriteria |
| Details |
1. Age<18 years
2. Other neurological disorders that cause motor deficits, such as Parkinson’s disease and peripheral neuropathy;
3. Severe aphasia resulting in communication difficulties that could influence the intervention and outcome measures;
4. Cognitive impairment resulting in cooperation difficulties (a score of≤24 in the Mini-Mental State Examination);
5. Severe pain impeding upper extremity rehabilitation (numeric pain rating scale score ≥ 7)
6. No significant visual dysfunction.
7. Contraindications for doing MRI.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Centralized |
|
Blinding/Masking
|
Open Label |
Primary Outcome
Modification(s)
|
| Outcome |
TimePoints |
Feasibility Outcome: Compliance with the treatment
Efficacy Outcome: Fugl Meyer score and Wolf motor function test
|
Feasibility Outcome: 3 months
Efficacy Outcome: Baseline and 3 months |
|
Secondary Outcome
Modification(s)
|
| Outcome |
TimePoints |
| Barthel Index (BI) & Quality of life scale (SF-36) |
Baseline & 3 months |
|
|
Target Sample Size
|
Total Sample Size="162" Sample Size from India="162"
Final Enrollment numbers achieved (Total)= "66"
Final Enrollment numbers achieved (India)="66" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
27/12/2021 |
| Date of Study Completion (India) |
11/07/2024 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response (Others) - Proposals should be directed to sylajapn@hotmail.com
- For how long will this data be available start date provided 07-11-2025 and end date provided 06-11-2028?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
|
Brief Summary
|
The proposed
project is to build a comprehensive, large-scale computational neural model of
the key parts of the brain involved in the control of upper extremities. The model
must simulate the effects of specific stroke lesions and their effects on arm
movements. The model allows customization to a given patient based on
measurements of the site, location, disruption in the structure-function
relation in the stroke-afflicted brain. Proposed treatment modalities will be
first simulated on the model, and only the most effective solutions will be
administered to the patient. The use of such large-scale, comprehensive
computational models for the treatment of neurological disease can be a
game-changer in clinical neuroscience. It has the potential to transform the
current empirical traditions of clinical neurology, into a quantitative, data
and model-driven, scientific practice. The objectives of the
project is - Development of the
large-scale, computational neuroscience model:
- Movement analysis
and modeling:
- Development of
Virtual Reality-based Gaming system
- Clinical: Evaluating
the feasibility and efficacy of virtual reality-based gaming in stroke
survivors with impairment of the upper extremity
- Neuroimaging:
Measurement of pre-treatment and post-treatment recovery process in the function of the brain using resting-state
functional imaging studies
Hypothesis: The hypothesis for our study is
that the proposed VR gaming-based rehabilitation scheme gives better clinical
outcomes than a comparable traditional rehabilitation scheme. Combined with the
computational modeling effort, it is expected that we can bridge the gaps in
terms of characterizing, on the one hand, the relation between VR gaming
parameters and the behavioral improvements and on the other hand probe the
neural substrates of these improvements. It is also envisaged that the
computational models allow us to customize the therapies for individual
patients. Study Methodology: In the patients who
fulfill the inclusion criteria, informed consent will be taken and then
baseline NIHSS, Wolf motor function test, Fugl Meyer score for upper limb will
be done. In addition, a quality-of-life scale - SF 36, mRS, and Barthel Index will
be done. Following this patients will be randomized either to intervention or
control group using the software. Then they undergo MRI brain protocol which
includes resting-state functional MRI which will be done at baseline and after
12 weeks of therapy. Each arm will receive
the therapy for 12 weeks, 3 sessions per week. Each session will be for 30-45
minutes each. The conventional arm will receive routine therapy for
strengthening and functional activities and the intervention arm will receive
training on virtual reality-based gaming. A repeat assessment of the Wolf
motor function test, Fugl Meyer score for upper limb, quality of life
assessment mRS, and Barthel Index will be done at the end of 3 months. In addition,10 healthy controls will undergo MRI brain
protocol including resting-state functional MRI which will be important for the
modeling. |